uniQure (QURE) Net Margin (2016 - 2026)

uniQure (QURE) recorded quarterly Net Margin of 1502.95% in Q1 2026, down 348.85% quarter-over-quarter from 334.84% in Q4 2025, and up 128180.0% on a YoY basis from N/an in Q1 2025.

uniQure (QURE) Net Margin (2016 - 2026) Analysis & Trends

uniQure's Net Margin history runs 11 years deep, the most recent figure standing at 1502.95% for Q1 2026.

  • In Q1 2026, Net Margin rose 128180.0% year-over-year to 1502.95%; the TTM figure through Mar 2026 stood at 1046.38% (up 3067.0% YoY), while the FY2025 annual figure was 1236.0%, down 35265.0% from the prior year.
  • Net Margin was 1502.95% for Q1 2026 at uniQure, down from 334.84% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6.63% in Q4 2022 to a low of 7859.36% in Q2 2022.
  • Historically, Net Margin has averaged 2212.15% across 5 years, with a median of 1502.95% in 2026.
  • Biggest YoY gain for Net Margin was 654850 bps in 2022; the steepest drop was 794547 bps in 2022.
  • A 5-year view of Net Margin shows it stood at 6.63% in 2022, then plunged by 16619 bps to 1094.42% in 2023, then fell by 28 bps to 1403.2% in 2024, then surged by 76 bps to 334.84% in 2025, then sank by 349 bps to 1502.95% in 2026.
  • The last three Net Margin figures came in at 1502.95% (Q1 2026), 334.84% (Q4 2025), and 2146.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn -1,502.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,502.95%
Dec 31, 2025 -334.84%
Sep 30, 2025 -2,146.01%
Jun 30, 2025 -716.82%
Mar 31, 2025 -2,784.75%
Dec 31, 2024 -1,403.20%
Sep 30, 2024 -1,940.45%
Jun 30, 2024 -506.01%
Mar 31, 2024 -773.34%
Dec 31, 2023 -1,094.42%
Sep 30, 2023 -6,366.10%
Jun 30, 2023 -2,827.17%
Mar 31, 2023 -1,450.27%
Dec 31, 2022 6.63%
Sep 30, 2022 -3,302.76%
Jun 30, 2022 -7,859.36%
Mar 31, 2022 -2,604.80%
Dec 31, 2021 14.23%
Sep 30, 2021 -1,836.65%
Jun 30, 2021 86.12%